SEC FORM 4SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
checkbox uncheckedCheck this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
checkbox checkedCheck this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Stein Steven H

(Last)(First)(Middle)
1801 AUGUSTINE CUT-OFF

(Street)
WILMINGTONDE19803

(City)(State)(Zip)
2. Issuer Name and Ticker or Trading Symbol
INCYTE CORP [ INCY ]
Foreign Trading Symbol
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
checkbox checkedOfficer (give title below)Other (specify below)
CMO & Head of Late-Stage Dev.
3. Date of Earliest Transaction (Month/Day/Year)
11/06/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
checkbox checkedForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/06/2026M8,539A$68.6239,455D
Common Stock11/06/2026M12,335A$72.2751,790D
Common Stock11/06/2026M16,428A$80.568,218D
Common Stock11/06/2026M15,054A$74.7883,272D
Common Stock11/06/2026M23,526A$77.67106,798D
Common Stock11/06/2026M18,331A$61.76125,129D
Common Stock11/06/2026M19,749A$61.18144,878D
Common Stock11/06/2026M12,305A$64.25157,183D
Common Stock11/06/2026M6,907A$68.25164,090D
Common Stock11/06/2026M16,428A$85.01180,518D
Common Stock11/06/2026M12,743A$90.56193,261D
Common Stock11/06/2026M15,054A$83.58208,315D
Common Stock11/06/2026M24,838A$83.2233,153D
Common Stock11/06/2026M879A$113.64234,032D
Common Stock11/06/2026M17,986A$113.64252,018D
Common Stock11/06/2026M19,091A$113.64271,109D
Common Stock11/06/2026S35,042D$116.0632(1)236,067D
Common Stock11/06/2026S22,336D$117.145(2)213,731D
Common Stock11/06/2026S60,270D$118.2729(3)153,461D
Common Stock11/06/2026S73,969D$119.1176(4)79,492D
Common Stock11/06/2026S48,576D$119.6639(5)30,916(6)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy)$68.6211/06/2026M8,539 (7)07/01/2028Common Stock8,539$01D
Employee Stock Option (right to buy)$72.2711/06/2026M12,335 (8)01/03/2029Common Stock12,335$00D
Employee Stock Option (right to buy)$80.511/06/2026M16,428 (9)01/16/2030Common Stock16,428$00D
Employee Stock Option (right to buy)$74.7811/06/2026M15,054 (10)01/18/2032Common Stock15,054$00D
Employee Stock Option (right to buy)$77.6711/06/2026M23,526 (11)07/01/2032Common Stock23,526$02,139D
Employee Stock Option (right to buy)$61.7611/06/2026M18,331 (12)07/13/2033Common Stock18,331$010,054D
Employee Stock Option (right to buy)$61.1811/06/2026M19,749 (13)01/17/2034Common Stock19,749$010,831D
Employee Stock Option (right to buy)$64.2511/06/2026M12,305 (14)07/14/2034Common Stock12,305$018,783D
Employee Stock Option (right to buy)$68.2511/06/2026M6,907 (15)07/14/2035Common Stock6,907$020,722D
Employee Stock Option (right to buy)$85.0111/06/2026M16,428 (16)07/01/2029Common Stock16,428$00D
Employee Stock Option (right to buy)$90.5611/06/2026M12,743 (17)01/14/2031Common Stock12,743$00D
Employee Stock Option (right to buy)$83.5811/06/2026M15,054 (18)07/01/2031Common Stock15,054$00D
Employee Stock Option (right to buy)$83.211/06/2026M24,838 (19)01/19/2033Common Stock24,838$02,258D
Incentive Stock Option (right to buy)$113.6411/06/2026M879 (20)01/16/2027Common Stock879$00D
Non-Qualified Stock Option (right to buy)$113.6411/06/2026M17,986 (20)01/16/2027Common Stock17,986$00D
Non-Qualified Stock Option (right to buy)$113.6411/06/2026M19,091 (21)01/16/2027Common Stock19,091$00D
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.56 to $116.55 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.64 to $117.63 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.64 to $118.635 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.64 to $119.63 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.65 to $119.79 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
6. This includes an aggregate of 29,338 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
7. Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
8. Beginning January 4, 2019, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2019 and the remainder vesting monthly over three years.
9. Beginning January 17, 2020, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2020 and the remainder vesting monthly over three years.
10. Beginning January 19, 2022, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2022 and the remainder vesting monthly over three years.
11. Beginning July 2, 2022, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
12. The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
13. Beginning January 18, 2024, options become exercisable in 37 installments, with the first 25% vesting on July 14, 2024 and the remainder vesting monthly over three years.
14. The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
15. The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
16. Beginning July 2, 2019, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
17. Beginning January 15, 2021, options become exercisable in 37 installments, with the first 25.00% vesting on July 2, 2021 and the remainder vesting monthly over three years.
18. Beginning July 2, 2021, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
19. Beginning January 20, 2023, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2023 and the remainder vesting monthly over three years.
20. Beginning January 17, 2017, options become exercisable in full on January 17, 2021.
21. Beginning January 17, 2017, options become exercisable in 37 installments, with the first 25.00% vesting on July 15, 2017 and the remainder vesting monthly over three years.
Remarks:
/s/ Elizabeth Feeney, Attorney-In-Fact11/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.